연구성과로 돌아가기
2024 연구성과 (231 / 286)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| WoS | SCOPUS | Document Type | Document Title | Abstract | Authors | Affiliation | ResearcherID (WoS) | AuthorsID (SCOPUS) | Author Email(s) | Journal Name | JCR Abbreviation | ISSN | eISSN | Volume | Issue | WoS Edition | WoS Category | JCR Year | IF | JCR (%) | FWCI | FWCI Update Date | WoS Citation | SCOPUS Citation | Keywords (WoS) | KeywordsPlus (WoS) | Keywords (SCOPUS) | KeywordsPlus (SCOPUS) | Language | Publication Stage | Publication Year | Publication Date | DOI | JCR Link | DOI Link | WOS Link | SCOPUS Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ○ | ○ | Article | Efficacy of Bronchial Artery Embolization for Clinically Suspected Bronchial Dieulafoy's Disease | Background: The efficacy of bronchial artery embolization (BAE) for bronchial Dieulafoy's disease (BDD) has not been well established.Objective: This study aimed to evaluate the safety and efficacy of BAE in patients with clinically suspected BDD presenting with major hemoptysis, and to describe angiographic findings.Methods: 17 patients (all men; mean age, 53.5 years) diagnosed with clinically suspected BDD by bronchoscopy (n = 7) or CT angiography (CTA) (n = 10) and who underwent BAE after directional and segmental localization of the target bronchus were enrolled. BAE was performed at the culprit bronchial artery traveling toward the target bronchus, regardless of the pathologic angiographic findings. Angiographic findings and clinical outcomes of BAE, including technical and clinical success, complication, recurrent hemoptysis, and follow-up imaging, were retrospectively reviewed.Results: Representative angiographic findings included parenchymal hypervascularity prominent in the lobe where the BDD was located (82.4%), bronchial artery hypertrophy (70.6%), and contrast extravasation into the bleeding bronchus (17.6%). BAE was technically successful in all patients. All hemoptysis ceased within 24 h. No procedure-related complications occurred. During a mean follow-up of 491.9 days, 1 (6%) patient experienced recurrent hemoptysis. Follow-up bronchoscopy or CT performed in 10 (58.8%) patients showed the disappearance of pre-existing lesions (n = 9) or glue cast within the target bronchial artery (n = 1).Conclusion: Bronchial angiography showed pathologic findings in most patients with clinically suspected BDD. BAE assisted by bronchoscopy or CTA localization is a safe and effective treatment for patients with clinically suspected BDD with excellent short- to mid-term results. | Cha, Jung Guen; Hong, Jihoon; Kim, Gab Chul; Park, Byunggeon; Park, Jongmin; Park, Seo Young; Shin, Kyung Min; Lim, Jae-Kwang; Lee, So Mi | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Radiol, 680 Gukchaebosang Ro, Daegu 41944, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, 807 Hoguk Ro, Daegu 41404, South Korea | 57206855971; 57215858314; 23004499400; 57211532915; 57216463879; 57210379391; 7402410737; 55515341400; 56824903400 | blushain@gmail.com; | CURRENT MEDICAL IMAGING | CURR MED IMAGING | 1573-4056 | 1875-6603 | 20 | SCIE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2024 | 1.1 | 79.0 | 0.75 | 2025-04-16 | 0 | 1 | Bronchial arteries; Therapeutic embolization; Bronchoscopy; CT angiography; Hemoptysis; Angiography | CRYPTOGENIC HEMOPTYSIS; MASSIVE HEMOPTYSIS | Angiography; Bronchial arteries; Bronchoscopy; CT angiography; Hemoptysis; Therapeutic embolization | Computerized tomography; Endoscopy; Pathology; Patient treatment; C reactive protein; contrast medium; cyanoacrylate; enbucrilate; hemoglobin; iodinated poppyseed oil; microsphere; polyvinyl alcohol; Bronchial artery; Bronchoscopy; Clinical outcome; CT angiography; Embolization; Follow up; Hemoptysis; Localisation; Mean ages; Therapeutic embolization; adult; aged; arterial embolization; Article; blood clotting disorder; bronchial artery; bronchiectasis; bronchus disease; clinical outcome; computed tomographic angiography; contrast medium extravasation; diastolic blood pressure; Dieulafoy disease; emphysema; female; fiberoptic bronchoscopy; follow up; hemoptysis; human; hypertrophy; laboratory test; leukocyte; lung parenchyma; male; oxygen saturation; pathology; people by smoking status; pneumonia; recurrent disease; retrospective study; submucosa; systolic blood pressure; tertiary care center; thorax pain; thrombocyte; tuberculosis; vascularization; very elderly; Angiography | English | 2024 | 2024 | 10.2174/0115734056280554231030092246 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Nontuberculous Mycobacterial Infection Mimicking Lung Cancer in a Patient with Usual Interstitial Pneumonia Pattern Interstitial Lung Disease: A Case Report | Background: It has been reported that structure damage in the parenchymal lung disease such as idiopathic pulmonary fibrosis (IPF) is associated with high susceptibility to nontuberculous mycobacterial (NTM) infection. Radiologic features of NTM lung disease in destructive lung parenchyma can be atypical, which can cause confusion with other diseases including malignancy. Prompt and accurate identification of newly developed lesions in the follow-up computed tomography (CT) of IPF patients is challenging but crucial. Case Report: We reported a case of an NTM infection in a patient with IPF, manifested as a mass-like consolidation with cavitation on chest CT, mimicking lung cancer. Conclusion: Being aware of the unusual radiologic features of NTM lung disease in IPF patients can be useful in the differential diagnosis of newly detected lesions. | Lee, Chaebin; Park, Jongsoo; Lim, Jae-Kwang; Park, Jongmin; Park, Byunggeon | Yeungnam Univ, Dept Radiol, Coll Med, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Radiol, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Chilgok Hosp, Dept Radiol, Daegu, South Korea | 58729376000; 57219376815; 55515341400; 57216463879; 57211532915 | pjsdr@ynu.ac.kr; | CURRENT MEDICAL IMAGING | CURR MED IMAGING | 1573-4056 | 1875-6603 | 20 | SCIE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2024 | 1.1 | 79.0 | 0 | 2025-04-16 | 1 | 1 | Nontuberculous mycobacterial infection; Lung cancer; Interstitial pneumonia; Interstitial lung disease; Computed tomography; Case report | Case report; Computed tomography; Interstitial lung disease; Interstitial pneumonia; Lung cancer; Nontuberculous mycobacterial infection | Biological organs; Computerized tomography; Diagnosis; azithromycin; carcinoembryonic antigen; clarithromycin; ethambutol; gamma interferon; neuron specific enolase; rifampicin; Case reports; Computed tomography; Idiopathic pulmonary fibrosis; Interstitial lung disease; Interstitial pneumonia; Interstitials; Lung Cancer; Mycobacterial; Mycobacterial infection; Nontuberculous mycobacterial infection; acid fast bacterium; aged; arterial gas; Article; atypical mycobacteriosis; blood gas analysis; bronchiectasis; bronchoalveolar lavage fluid; bronchoscopy; cancer patient; case report; chronic inflammation; clinical article; computer assisted tomography; coughing; differential diagnosis; disease exacerbation; dyspnea; erythrocyte sedimentation rate; fibrosing alveolitis; follow up; granulomatosis; human; interstitial lung disease; interstitial pneumonia; laboratory test; lung cancer; lung cavitation; lung consolidation; lung parenchyma; male; Mycobacterium intracellulare; Mycobacterium tuberculosis; polymerase chain reaction; radiological parameters; reticular opacity; thorax radiography; Pulmonary diseases | English | 2024 | 2024 | 10.2174/1573405620666230725093800 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||
| ○ | ○ | Article | Primary Thymic Mucinous Adenocarcinoma with Extensive Punctate and Amorphous Calcifications: A Case Report | Background: Primary thymic mucinous adenocarcinoma is an extremely rare and aggressive tumor with poor prognosis. The tumor may present as a heterogeneous solid or cystic mass accompanied by calcifications. However, clinical and radiologic features of the tumor are not well known due to the rarity of the disease, which makes accurate diagnosis difficult. Case Presentation: Here we present a rare case of primary thymic mucinous adenocarcinoma in the anterior mediastinum, including computed tomography (CT) and magnetic resonance imaging (MRI) findings. Chest computed tomography revealed a large anterior mediastinal mass with extensive calcifications with poor enhancement. MRI showed that anterior mediastinal mass showed intermediate signal intensity on T1-weighted images (T1WI), high SI on T2-weighted images (T2WI), and heterogeneous enhancement. Biopsy was performed and the anterior mediastinal tumor was diagnosed as thymic mucinous adenocarcinoma by histopathologic examination and immunohistochemical staining. Conclusion: Thymic mucinous adenocarcinomas could be included in differential diagnoses of anterior mediastinal tumors showing extensive calcification, and common imaging findings of mucinous adenocarcinoma such as T2 high signal intensity and heterogeneous enhancement on MRI may be helpful to diagnose thymic mucinous adenocarcinoma. | Cho, Hangjun; Park, Jongmin; Shin, Kyung Min; Park, Seo Young; Park, Byunggeon; Jeong, Ji Yun; Kim, Jae-Hui | Kyungpook Natl Univ, Sch Med, Dept Radiol, 680 Gukchaebosang Ro, Daegu 41944, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Pathol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | 58453012100; 57216463879; 7402410737; 57210379391; 57211532915; 57205472984; 57416959900 | redzon7543@gmail.com; | CURRENT MEDICAL IMAGING | CURR MED IMAGING | 1573-4056 | 1875-6603 | 20 | SCIE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2024 | 1.1 | 79.0 | 0.75 | 2025-04-16 | 1 | 1 | Mucinous; Adenocarcinoma; Calcification; Computed tomography; Magnetic resonance imaging; Thymus | TUMORS | Adenocarcinoma; Calcification; Computed tomography; Magnetic resonance imaging; Mucinous; Thymus | Adenocarcinoma, Mucinous; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Tomography, X-Ray Computed; Biomineralization; Bone; Computerized tomography; Diagnosis; Image enhancement; Tumors; C reactive protein; carcinoembryonic antigen; contrast medium; cytokeratin 20; cytokeratin 7; fluorodeoxyglucose; homeobox protein Nkx 2.1; mucin; transcription factor Cdx2; Adenocarcinoma; Calcification; Case reports; Computed tomography; Cystic mass; Heterogeneous solid; Mediastinal mass; Mucinoi; Signal intensities; Solid mass; aged; amorphous calcification; Article; blood pressure; body temperature; breathing rate; calcification; cancer chemotherapy; case report; clinical article; colloid carcinoma; computer assisted tomography; contrast enhancement; dyspnea; extensive punctate calcification; heart rate; histopathology; human; human tissue; immunohistochemistry; interstitial lung disease; lung consolidation; lung disease; male; maximum standardized uptake value; mediastinum; mediastinum mass; nuclear magnetic resonance imaging; oxygen saturation; peribronchial cuffing; pericardial effusion; pleura effusion; positron emission tomography-computed tomography; primary thymic mucinous adenocarcinoma; T1 weighted imaging; T2 weighted imaging; tumor growth; ultrasound guided biopsy; colloid carcinoma; diagnostic imaging; differential diagnosis; pathology; x-ray computed tomography; Magnetic resonance imaging | English | 2024 | 2024 | 10.2174/1573405620666230606125454 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Asteroseismic Searching for Environmental Influence in Star Clusters Observed by Kepler/K2 | In this paper, we investigate asteroseismic scaling-relations of evolved stars in star clusters observed by Kepler/K2, aiming to address the issue of whether observed stellar oscillations are influenced by environmental factors, as there are interesting phenomena relating to the stellar pulsations observed in star clusters. Specifically, we compare statistical properties of distributions including Delta nu, nu(max), H-Gauss, delta nu(env), and delta nu(02) derived from red giant branch (RGB) and red clump (RC) stars in two pairs of star clusters: NGC 2682 - NGC 6819 and NGC 1817 - NGC 6811. We have found that the slopes of relations between nu(max) and Delta nu and between H-Gauss and nu(max) associated with RC stars in the more compact star clusters, NGC 2682 and NGC 1817, are in common less steep compared with those for NGC 6819 and NGC 6811. It is also found that the slopes of the relation between delta nu(env) and nu(max) from RC stars in the more compact star clusters are in common steeper compared with those for the others. For the relation between delta nu(02) and Delta nu obtained from RGB stars, the slope resulting from NGC 2682 and NGC 6819 is indistinguishable. The Kolmogorov-Smirnov tests conducted on RC stars in the pairs of NGC 2682 and NGC 6819, as well as NGC 1817 and NGC 6811, indicate that all the seismic quantities considered in this paper are drawn from different distributions. We conclude, therefore, that the properties of star clusters should be considered when asteroseismic data obtained from stars within star clusters are interpreted. | Jo, Yun-A; Chang, Heon-Young | Kyungpook Natl Univ, Dept Astron, Daegu 41566, South Korea | 57192696730; 7407524806 | hyc@knu.ac.kr; | JOURNAL OF THE KOREAN ASTRONOMICAL SOCIETY | J KOREAN ASTRON SOC | 1225-4614 | 57 | 2 | SCIE | ASTRONOMY & ASTROPHYSICS | 2024 | 0.8 | 79.2 | 0 | 2025-05-07 | 0 | 0 | asteroseismology; methods: data analysis; stars: fundamental parameters | SOLAR-LIKE OSCILLATIONS; NU(MAX) SCALING RELATION; RED GIANTS; NGC 6791; FREQUENCY-SEPARATION; STELLAR EVOLUTION; POWER EXCESS; MASS-LOSS; PARAMETERS; MISSION | asteroseismology — methods: data analysis — stars: fundamental parameters | English | 2024 | 2024-07 | 10.5303/jkas.2024.57.2.145 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||
| ○ | ○ | Article | Exploring Asteroseismic Relations with Partial Correlation Coefficients along Evolutionary Status | Much effort has been carried out to calibrate and revise asteroseismic relations, given their importance of relations in asteroseismology in determining fundamental parameters of stars. In this study, we statistically explore asteroseismic relations with partial correlation coefficients to determine the most fundamental parameters, separately analyzing asteroseismic data based on the evolutionary status of stars from main sequence up to core helium-burning red-clump stars. We have found that regardless of the evolutionary status of the sampled stars the surface gravity and density of stars strongly influence the observed correlations. More importantly, it is found that indirect correlations derived considering the influence of confounding parameters are subject to the evolutionary status. For example, the observed correlation of the large frequency separation Ov v with the central frequency v max is influenced by the stellar mass, radius, and luminosity only for main sequence stars. The observed correlation of the width of the Gaussian envelope delta v env with v max is influenced by the stellar mass, effective temperature, radius, and luminosity for main-sequence and subgiant stars. The observed relation between Ov v and the small frequency separation delta v 02 is influenced by the stellar mass, radius, and luminosity for main-sequence and subgiant stars. In contrast, effective temperature, metallicity, and age do not seem to significantly affect the observed correlations. Finally, we conclude by discussing implication of our findings. | Jo, Yun-A; Chang, Heon-Young | Kyungpook Natl Univ, Dept Astron, Daegu 41566, South Korea | 57192696730; 7407524806 | hyc@knu.ac.kr; | JOURNAL OF THE KOREAN ASTRONOMICAL SOCIETY | J KOREAN ASTRON SOC | 1225-4614 | 57 | 2 | SCIE | ASTRONOMY & ASTROPHYSICS | 2024 | 0.8 | 79.2 | 0 | 2025-05-07 | 0 | 0 | asteroseismology - methods; data analysis - stars; fundamental parameters | SOLAR-LIKE OSCILLATIONS; NU(MAX) SCALING RELATION; KEPLER RED GIANTS; CLUSTERS NGC 6791; FUNDAMENTAL PROPERTIES; FREQUENCY-SEPARATION; STELLAR GRANULATION; ECLIPSING BINARIES; MAIN-SEQUENCE; K-GIANTS | asteroseismology; methods: data analysis; stars: fundamental parameters | English | 2024 | 2024-07 | 10.5303/jkas.2024.57.2.135 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||
| ○ | Letter | Floor After Floor Solution | Jeong, Won Kyun | Kyungpook Natl Univ, Daegu, South Korea | FIBONACCI QUARTERLY | FIBONACCI QUART | 0015-0517 | 62 | 4 | ESCI | MATHEMATICS | 2024 | 0.4 | 79.2 | 0 | English | 2024 | 2024-11 | 바로가기 | 바로가기 | |||||||||||||||||
| ○ | ○ | Article | Galaxy-Galaxy Blending in SPHEREx Survey Data | The Spectro-Photometer for the History of the Universe, Epoch of Reionization and Ices Explorer (SPHEREx) will provide all -sky spectral survey data covering optical to mid -infrared wavelengths with a spatial resolution of 6."2, which can be widely used to study galaxy formation and evolution. We investigate the galaxy -galaxy blending in SPHEREx datasets using the mock galaxy catalogs generated from cosmological simulations and observational data. Only similar to 0.7% of the galaxies will be blended with other galaxies in all -sky survey data with a limiting magnitude of 19 AB mag. However, the fraction of blended galaxies dramatically increases to similar to 7-9% in the deep survey area around the ecliptic poles, where the depth reaches similar to 22 AB mag. We examine the impact of the blending in the number count and luminosity function analyses using the SPHEREx data. We find that the number count can be overestimated by up to 10-20% in the deep regions due to the flux boosting, suggesting that the impact of galaxy -galaxy blending on the number count is moderate. However, galaxy -galaxy blending can marginally change the luminosity function by up to 50% over a wide range of redshifts. As we only employ the magnitude limit at K-s -band for the source detection, the blending fractions determined in this study should be regarded as lower limits. | Dachan, Kim; Song, Hyunmi; Kim, Yigon; Kim, Minjin; Shim, Hyunjin; Kim, Dohyeong; Kim, Yongjung; Lee, Bomee; Lee, Jeong Hwan; Jeong, Woong-Seob; Yang, Yujin | Chungnam Natl Univ, Dept Astron & Space Sci, Daejeon 34134, South Korea; Kyungpook Natl Univ, Dept Astron & Atmospher Sci, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Earth Sci Educ, Daegu 41566, South Korea; Pusan Natl Univ, Dept Earth Sci, Busan 46241, South Korea; Korea Astron & Space Sci Inst, Daejeon 34055, South Korea; Kyungpook Natl Univ, Ctr High Energy Phys, Daegu 41566, South Korea; Univ Sci & Technol, Daejeon 34113, South Korea | , Yong Jung Kim/JRW-0681-2023; Kim, Minjin/AAU-9910-2020; Shim, Hyunjin/LZI-7486-2025 | 59198938300; 35749280400; 57376307100; 56898213300; 14061137700; 55574223678; 59622148200; 55832276300; 57195344163; 7102145940; 7409384232 | hmsong@cnu.ac.kr;mkim@knu.ac.kr; | JOURNAL OF THE KOREAN ASTRONOMICAL SOCIETY | J KOREAN ASTRON SOC | 1225-4614 | 57 | 1 | SCIE | ASTRONOMY & ASTROPHYSICS | 2024 | 0.8 | 79.2 | 0 | 2025-05-07 | 0 | 0 | surveys; infrared: galaxies; galaxies: abundances; galaxies: luminosity function; galaxies: groups: general | SEMIANALYTIC FORECASTS; INFRARED SURVEY; LIGHT-CONES; DEEP; SIMULATIONS; UNIVERSE; CANDELS | galaxies: abundances; galaxies: groups: general; galaxies: luminosity function; infrared: galaxies; surveys | English | 2024 | 2024-01 | 10.5303/jkas.2024.57.1.45 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | How Are the Terms of the Angular Distance between Celestial Bodies Defined in Korean Historical Records? | Korean historical literatures offer numerous records on astronomical phenomena such as eclipses, comets, and close approaches, etc. Records of close approaches often use specific terms to describe the angular distance, which lack translation into modern numerical values. We study the usage of the five commonly used terms, namely, Entry ((sic), En), Invasion ((sic), In), Occultation ((sic), Oc), Eclipse ((sic), Ec), as well as the unit Chi ((sic)). Our analysis is based on more than 2,300 records from Goryeo (918-1392 CE) and Joseon (1392-1910 CE) Dynasties. Through statistical analysis, we determine their quantitative definitions. We convert the lunisolar calendar to the Julian and Gregorian date and utilize the modern ephemeris DE431 to calculate the angular distance between celestial bodies. We find that the angular distances of the terms En, In, Oc, and Ec correspond to respectively 1.78 degrees(+2.36)(-0.51) , 0.44 degrees(+1.15)(-0.31), and 0.29 degrees(+2.61 )(-0.16)for the Goryeo Dynasty and 1.36 degrees(+1.15)(-0.64), 0.51 degrees(+1.11)(-0.32), 0.25 degrees(+0.27)(-0.32) and 0.21 degrees(+0.25)(-0.11) Joseon Dynasty. Additionally, we determine the angular size of the unit Chi by using the records from Korean chronicles along with the drawings of comets' tails in the Daily Log ((sic)). We estimate the unit Chi to be 1.11 degrees(+0.46)(-0.40) numerical definition was consistent throughout the two dynasties in Korea. Furthermore, we find that the terms were used to describe the closest approach and that there is no observational bias in the angular distances against the apparent magnitudes of the objects. We show that the terms En, In, Oc, and Ec represent decreasing angular distance in that order and this ordering was consistent in both dynasties. | Lee, Hyojun; Yang, Hong-Jin; Yoon, Suk-Jin; Park, Myeong-Gu | Korea Astron & Space Sci Inst KASI, Daejeon 34055, South Korea; Yonsei Univ, Dept Astron, Seoul 03722, South Korea; Univ Sci & Technol UST, Daejeon 34113, South Korea; Kyungpook Natl Univ, Dept Astron & Atmospher Sci, Daegu 41566, South Korea | Yoon, Suk-Jin/KTI-5482-2024 | 58931545900; 9746218100; 8850092500; 7404490321 | hjyang@kasi.re.kr; | JOURNAL OF THE KOREAN ASTRONOMICAL SOCIETY | J KOREAN ASTRON SOC | 1225-4614 | 57 | 1 | SCIE | ASTRONOMY & ASTROPHYSICS | 2024 | 0.8 | 79.2 | 0 | 2025-04-16 | 0 | 0 | history and philosophy of astronomy; celestial mechanics; occultations; eclipses; methods data analysis; standards | ORBITAL ELEMENTS | celestial mechanics; eclipses; history and philosophy of astronomy; methods: data analysis; occultations; standards | English | 2024 | 2024-01 | 10.5303/jkas.2024.57.1.1 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Initial Results of Low Earth Orbit Space Radiation Dosimeter on Board the Next Generation Small Satellite-2 | As human exploration goals shift from missions in low Earth orbit (LEO) to long-duration interplanetary missions, radiation protection remains one of the key technological issues that must be resolved. The low Earth orbit space radiation dosimeter (LEO-DOS) instrument to measure radiation levels and create a global dose map in the LEO on board the the next generation small satellite-2 (NEXTSat-2) was launched successfully on May 25, 2023 using the Nuri KSLV-III in Korea. The NEXTSat-2 orbits the Earth every 100 minutes, in an orbit with an inclination of 97.8 degrees and an altitude of about 550 km above sea level. The LEO-DOS is equipped with a particle dosimeter (PD) and a neutron spectrometer (NS), which enable the measurement of dosimetric quantities such as absorbed dose (D), dose equivalent (H) for charged particles and neutrons. To verify the observations of LEO-DOS, we conducted a radiation dose estimation study based on the initial results of LEO-DOS, measured from June 2023 to September 2023. The study considered four source categories: (i) galactic cosmic ray particles; (ii) the South Atlantic Anomaly region of the inner radiation belt (IRB); (iii) relativistic electrons and/or bremsstrahlung in the outer radiation belt (ORB); and (iv) solar energetic particle (SEP) events. | Nam, Uk-Won; Park, Won-Kee; Youn, Sukwon; Kwak, Jaeyoung; Sohn, Jongdae; Moon, Bongkon; Lee, Jaejin; Choi, Young-Jun; Kim, Jungho; Kim, Sunghwan; Kim, Hongjoo; Park, Hwanbae; Ye, Sung-Joon; Park, Hongyoung; Jang, Taeseong | Korea Astron & Space Sci Inst, Space Sci Div, Daejeon 34055, South Korea; Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Appl Bioengn, Seoul 08826, South Korea; Univ Sci & Technol, Daejeon 34113, South Korea; Korea Res Inst Stand & Sci, Daejeon 34113, South Korea; Cheongju Univ, Dept Radiol Sci, Cheongju 28503, South Korea; Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea; Korea Adv Inst Sci & Technol, Satellite Technol Res Ctr, Daejeon 34141, South Korea | 6602840978; 35285730800; 57210900037; 57222142268; 55193404200; 14825351800; 55949810000; 55685945500; 56784564000; 36165569900; 58483690400; 58642658300; 7202088315; 36127983300; 7102425995 | uwnam@kasi.re.kr; | JOURNAL OF ASTRONOMY AND SPACE SCIENCES | J ASTRON SPACE SCI | 2093-5587 | 2093-1409 | 41 | 3 | ESCI | ASTRONOMY & ASTROPHYSICS | 2024 | 0.8 | 79.2 | 0 | 2025-05-07 | 2 | 1 | low Earth orbit; space radiation; next generation small satellite-2 (NEXTSat-2); charged particles dose; neutrons dose; dose map | PARTICLE | charged particles dose; dose map; low Earth orbit; neutrons dose; next generation small satellite-2 (NEXTSat-2); space radiation | English | 2024 | 2024-09 | 10.5140/jass.2024.41.3.195 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma | Background/Aim: CXCR3B has been positively involved in the inhibition of cancer and angiogenesis. The present study investigated the role of CXCR3B in a cell model of hepatocellular carcinoma, SK-Hep1. Materials and Methods: The blockade of CXCR3B expression in SK-Hep1 was investigated in terms of cell viability, cell cycle, and cell apoptosis using MTT assay and flow cytometry. In addition, the effect of blocking CXCR3B expression on cell migration and invasion was examined using scratch motility, transwell migration, and invasion assays. Furthermore, the cytotoxic effect of NK-92 cells against CXCR3B blocked SK-Hep1 was analyzed using the CytoTox96 assay, and the expression of NKp30+, NKG2D+, and NKG2C+ on NK-92 cells in a co- culture with SK-Hep1 was measured using flow cytometry. Results: Blocking CXCR3B expression had no effect on the viability, cell cycle or apoptosis of SK-Hep1 cells. However, blockade of CXCR3B expression significantly increased the migratory and invasive ability of SK-Hep1 along with increased protein expression of slug, vimentin, and N-cadherin. CXCR3B blockade reduced the cytotoxicity of NK-92 against SK-Hep1 and inhibited the expression of activating receptors, NKp30+, NKG2D+, and NKG2C+ in NK-92 cells. Conclusion: CXCR3B may play a positive role in suppressing HCC by attenuating natural killer cell cytotoxicity against HCC. | Lee, Hwan hee; Oh, Seoyeon; Kang, Hyojeung; Cho, Hyosun | Duksung Womens Univ, Coll Pharm, Seoul, South Korea; Duksung Womens Univ, Duksung Innovat Drug Ctr, Seoul, South Korea; Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, Daegu, South Korea | 56271051000; 59464652000; 8979751700; 55572361200 | hyosun1102@duksung.ac.kr;hkang72@knu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 44 | 12 | SCIE | ONCOLOGY | 2024 | 1.7 | 79.3 | 0 | 2025-05-07 | 0 | 0 | EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; NATURAL-KILLER-CELLS; NK CELLS; RECEPTOR; ACTIVATION; INNATE; TARGET; AXIS | CXCR3B; HCC; NK cells; SK-Hep1 | Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Killer Cells, Natural; Liver Neoplasms; Natural Cytotoxicity Triggering Receptor 3; Neoplasm Invasiveness; NK Cell Lectin-Like Receptor Subfamily K; Receptors, CXCR3; Snail Family Transcription Factors; Vimentin; biological marker; cxcr3b protein; natural cytotoxicity triggering receptor 3; natural killer cell receptor NKG2D; nerve cell adhesion molecule; nkg2c protein; protein; short hairpin RNA; transcription factor Slug; unclassified drug; vimentin; chemokine receptor CXCR3; CXCR3 protein, human; KLRK1 protein, human; natural cytotoxicity triggering receptor 3; natural killer cell lectin like receptor subfamily K; NCR3 protein, human; SNAI1 protein, human; transcription factor Snail; vimentin; antineoplastic activity; apoptosis; Article; cell cycle assay; cell invasion; cell migration; coculture; controlled study; cytotoxicity; down regulation; flow cytometry; gene knockdown; human; human cell; liver cell carcinoma; MTT assay; natural killer cell; NK-92 cell line; protein expression; protein function; SK-HEP-1 cell line; transwell assay; wound healing assay; apoptosis; cell motion; cell proliferation; cell survival; gene expression regulation; immunology; liver tumor; metabolism; pathology; tumor cell line; tumor invasion | English | 2024 | 2024-12 | 10.21873/anticanres.17357 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway | Background/Aim: Human melanoma-associated antigen A2 (hMAGEA2) family members play several roles in many types of cancer and have been explored as potential prognostic markers. In this study, we investigated the molecular mechanism underlying hMAGEA2-mediated tumorigenesis of prostate cancer. Materials and Methods: Immunohistochemistry and western blot were used to assess protein expression whereas microarray and quantitative reverse transcription-PCR determined mRNA expression. CCK-8 assay was used to determine cell proliferation. Colony formation assay was used to examine tumorigenesis. Migration and invasion were examined using a transwell assay. Propidium iodide (PI)/Annexin V double staining was performed to measure apoptosis. Transcriptional activity was measured using Dual-luciferase reporter assay. Results: hMAGEA2 was highly over-expressed in human prostate cancer tissues compared to benign prostatic hyperplasia tissues. To elucidate its biological function in prostate cancer, we established two stable hMAGEA2-knockdown prostate cancer cell lines, PC3M and 22RV1, and found that they presented significantly decreased proliferation, anchorage-independent colony formation, migration, and invasion. As hMAGEA2 knockdown suppressed prostate cancer cell growth, we examined its potential influence on tumor apoptosis. hMAGEA2-knockdown cell lines displayed early apoptosis. Moreover, knockdown of hMAGEA2 resulted the down-regulation of EFNA3 expression. Luciferase assay showed that hMAGEA2 bound to the EFNA promoter region and regulated its transcription. Down-regulation of EFNA3 expression led to decreased Ras/Braf/MEK/Erk1/2 phosphorylation and, consequently, inhibited prostate cancer progression. Conclusion: hMAGEA2 promotes prostate cancer growth, metastasis, and tumorigenesis by regulating the EFNA3-Erk1/2 signaling pathway, indicating its potential as a therapeutic marker for prostate cancer. | Han, Sehyeon; Jang, Soyoung; Lee, Seoung-Woo; Kim, Hee-Yeon; Kim, Wansoo; Kim, Hyeon-Gyeom; Park, Jin-Kyu; Han, Jee Eun; Ryoo, Zae Young; Seah, Ethan; Kim, Choonok; Lee, Jiyeon; Park, Song; Choi, Seong-Kyoon | Honam Univ, Coll Hlth Sci, Dept Compan Anim Ind, Gwangju, South Korea; Kyungpook Natl Univ, Sch Life Sci, FOUR KNU Creat Biores Grp BK21, Daegu, South Korea; DGIST, Core Prot Resources Ctr, Daegu, South Korea; DGIST, Div Biomed Technol, 333 Techno Jungang Daero, Daegu 42988, South Korea; Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; J INTS BIO Inc, Seoul, South Korea; Gyeongsang Natl Univ, Div Anim Sci, 501 Jinju Daero, Jinju Si 52828, Gyeongsangnam D, South Korea; Gyeongsang Natl Univ, Inst Agr & Life Sci IALS, Jinju, South Korea | RYOO, ZAEYOUNG/AAQ-1573-2020 | 57210915063; 57139360300; 57218827581; 58368914700; 57352897900; 57210911747; 35213723500; 57214671240; 16937104900; 59196775600; 59195731100; 59196567700; 57139047900; 55505432500 | cristaling9816@gnu.ac.kr;cskbest@dgist.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 44 | 7 | SCIE | ONCOLOGY | 2024 | 1.7 | 79.3 | 0 | 2025-05-07 | 0 | 0 | Prostate cancer; human melanoma-associated antigen A2; ephrin A3; RAS/MAPK/Erk1/2 signaling | POOR-PROGNOSIS; ENDONUCLEASE-G; TUMOR; APOPTOSIS; MAGEA2; EPH; PROLIFERATION; ANTIGEN; TARGET; GLIOMA | ephrin A3; human melanoma-associated antigen A2; Prostate cancer; RAS/MAPK/Erk1/2 signaling | Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Prostatic Neoplasms; Transcription Factors; apoptosis inducing factor; baculoviral IAP repeat containing protein 5; beta actin; caspase 3; endonuclease G; human melanoma associated antigen A2; lipocortin 5; melanoma antigen; messenger RNA; mitogen activated protein kinase 1; mitogen activated protein kinase 3; nerve cell adhesion molecule; propidium iodide; protein bcl 2; protein bcl xl; STAT1 protein; unclassified drug; uvomorulin; vimentin; EAF2 protein, human; transcription factor; 22Rv1 cell line; apoptosis; Article; cancer growth; cancer tissue; carcinogenesis; cell migration; cell proliferation; clinical article; colony formation; controlled study; down regulation; gene expression; gene knockdown; gene overexpression; human; human cell; human tissue; immunofluorescence; immunohistochemistry; luciferase assay; male; migration; mRNA expression level; PC-3M cell line; promoter region; prostate cancer; prostate hypertrophy; protein expression; protein expression level; real time reverse transcription polymerase chain reaction; signal transduction; transwell assay; tumor invasion; Western blotting; apoptosis; cell motion; cell proliferation; disease exacerbation; gene expression regulation; genetics; MAPK signaling; metabolism; pathology; prostate tumor; tumor cell line | English | 2024 | 2024-07 | 10.21873/anticanres.17097 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | Article | PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Background/aim: Durvalumab consolidation is less effective in patients with epidermal growth factor receptor mutant (EGFR M+) NSCLC. Studies of durvalumab on EGFR M+ NSCLC as an expression of programmed death-ligand 1 (PD-L1) expression are limited. The purpose of this study was to determine the effect of durvalumab on PD-L1 expression in EGFR M+ patients. Patients and methods: This study included 249 unresectable stage III NSCLC patients treated with durvalumab. The primary outcome was progression-free survival (PFS). Cox multivariate analysis was performed based on EGFR and PD-L1 statuses: EGFR M-, PD-L1 >= 50% (cohort A); EGFR M-, PD-L1 = 50% (cohort C); and EGFR M+, PD-L1 = 50% compared with EGFR M- patients. A therapeutic role of durvalumab in patients with EGFR M+, high PD-L1 unresectable stage III NSCLC should be considered. | Kim, Insu; Choi, Sun Ha; Lee, Shin Yup; Yoo, Seung Soo; Park, Ji Eun; Shin, Kyeong-Cheol; Jang, Jong Geol; Hong, Kyung Soo; Kwon, Yong Shik; Park, Sun Hyo; Choi, Keum-Ju; Jung, Chi Young; Kim, Mi-Hyun; Kim, Soo Han; Seol, Hee Yun; Kim, Jehun; Park, Jin-Han; Kim, Tae Hoon; Eom, Jung Seop; Ahn, June Hong | Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea; Keimyung Univ, Sch Med, Dept Internal Med, Busan, South Korea; Daegu Catholic Univ, Coll Med, Dept Internal Med, Daegu, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Sch Med, 179 Gudeok Ro, Busan 49241, South Korea; Pusan Natl Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med,Yangsan Hosp, Yangsan, South Korea; Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea; Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea | Park, Sun Hyo/JVN-6216-2024; kim, Tae-hoon/GXF-5826-2022; Ahn, June/AAB-3093-2019 | ejspulm@pusan.ac.kr;fireajh@gmail.com; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 44 | 10 | SCIE | ONCOLOGY | 2024 | 1.7 | 79.3 | 0 | NSCLC; EGFR; PD-L1; durvalumab | CELL LUNG-CANCER; CHEMORADIOTHERAPY; MUTATIONS | English | 2024 | 2024-10 | 10.21873/anticanres.1727 | 바로가기 | 바로가기 | 바로가기 | |||||||||
| ○ | ○ | Article | Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma | Background/Aim: Given the high frequency and mortality rate of lung cancer, diverse molecular studies have been undertaken to understand cancer pathophysiology and develop novel treatment strategies. The PDIA4 gene, which is involved in protein assembly and endoplasmic reticulum homeostasis, is overexpressed in various lung cancer subtypes. However, its exact function in lung adenocarcinoma (LUAD) remains elusive. The study aimed to investigate the role of PDIA4 in LUAD and explore its role as double-agent gene. Materials and Methods: PDIA4 expression was knocked out in A549 and LA-4 lung adenoma cells using the Crispr/Cas9 technology. Cell growth, migration, and apoptosis were analyzed in control and PDIA4-deficient cells. Results: PDIA4 deficiency resulted in increased cell growth, enhanced migration capacity, and greater resistance to apoptosis in both A549 and LA-4 lung cancer cells. Mechanistically, up-regulation of oxidative stress followed by NF-KB activation may contribute to tumor-promoting effects observed upon PDIA4 silencing. Conclusion: PDIA4 appears to function as a tumor suppressor in lung adenocarcinoma, suggesting that PDIA4 may act as a double-agent gene, with roles both on tumor suppression and promotion depending on the context. | Kim, Hyeon Ji; Kim, Do-Yeon | Kyungpook Natl Univ, Sch Dent, Dept Pharmacol, 2177 Dalgubeoldaero, Daegu 41940, South Korea | Kim, Do-Yeon/AET-3021-2022 | 57216816929; 57203012542 | dykim82@knu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 44 | 10 | SCIE | ONCOLOGY | 2024 | 1.7 | 79.3 | 0 | 2025-05-07 | 1 | 1 | PDIA4; lung adenocarcinoma; tumor suppressor; double-agent gene | CELL-DEATH; CANCER; GROWTH | double-agent gene; lung adenocarcinoma; PDIA4; tumor suppressor | A549 Cells; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; CRISPR-Cas Systems; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Oxidative Stress; Protein Disulfide-Isomerases; almonertinib; antineoplastic agent; beta actin; epidermal growth factor receptor; epidermal growth factor receptor kinase inhibitor; gefitinib; lazertinib; messenger RNA; osimertinib; protein disulfide isomerase; RNA; tumor promoter; unclassified drug; PDIA4 protein, human; protein disulfide isomerase; A-549 cell line; antineoplastic activity; antitumorigenic activity; apoptosis; Article; cancer cell; cancer growth; cancer inhibition; cell growth; cell migration; chemoluminescence; clustered regularly interspaced short palindromic repeat; controlled study; CRISPR-CAS9 system; endoplasmic reticulum; gene; homeostasis; human; human cell; immunoblotting; in vitro study; JNK signaling; lung adenocarcinoma; lung adenoma; lung cancer; mortality rate; NF kB signaling; oxidative stress; pathophysiology; protein assembly; protein processing; small cell lung cancer; transwell assay; tumor promotion; upregulation; wound healing assay; wound healing rate; apoptosis; cell motion; cell proliferation; CRISPR Cas system; gene expression regulation; genetics; lung adenocarcinoma; lung tumor; metabolism; pathology; tumor cell line | English | 2024 | 2024-10 | 10.21873/anticanres.17260 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | Article | Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study | Background/Aim: This study investigated the treatment patterns and prognosis of patients with metastatic or unresectable colorectal cancer (mCRC) treated with chemotherapy with targeting agents. Patients and Methods: This longitudinal multicenter study included 963 patients with mCRC who were treated in Korea between 2016 and 2020. Treatment patterns and efficacy were compared according to the mutation status and clinical factors. Results: As first-line therapy, most of the patients (83.5%) received FOLFOX plus bevacizumab (35.4%), followed by FOLFIRI plus bevacizumab (18.8%), FOLFIRI plus cetuximab (17.0%), and FOLFOX plus cetuximab (12.3%). Bevacizumab was the most frequent agent (78.8%) combined with chemotherapy in RAS-mutated CRC, while cetuximab (57.2%) in RAS wild-type CRC. Cetuximab was frequently combined with a doublet regimen in patients with left-sided CRC than in those with right-sided CRC (34.4% vs. 16%). As second-line therapy, most patients (63.4%) also received doublet regimens with bevacizumab, and FOLFIRI plus aflibercept was administered in 15.1%. The objective response rate with FOLFIRI plus cetuximab was significantly higher in patients with left-sided CRC than in those with right-sided CRC (59.2% vs. 30.8%, p=0.008) and marginally higher in patients with RAS wild-type CRC than in those with RAS-mutated CRC (55.6% vs. 0.0%, p=0.092). Progression-free survival (PFS) with FOLFOX plus bevacizumab was significantly shorter than that with FOLFIRI plus bevacizumab (p=0.030) in RAS-mutated CRC, whereas there were no significant differences between regimens in RAS wild-type CRC. Conclusion: In patients with unresectable metastatic colorectal cancer, doublet chemotherapy with targeting agents is the most common therapy and efficacy depends on the mutation status as well as clinical factors. © 2024 International Institute of Anticancer Research. All rights reserved. | Kim, Jwa Hoon; Cha, Yongjun; Shin, Sang Joon; Park, Young Suk; Kang, Jung Hun; Kim, Chan; Lim, Sung Hee; Kang, Myoung Joo; Kim, Jong Gwang; Hwang, In G.Y.U.; Choi, Jong-Kwon; Shin, Seong Hoon; Kang, Seok Yun; Lee, Sang-Cheol; Lim, Seung Taek; Kim, Jung Sun; Jeung, Hei-Cheul; Kang, Myoung Hee; Choi, In Sil; Ryu, Hye Won; Lee, Kyung Hee; Lee, Moon Hee; Lee, Ji Young; Park, Ji Hyun; Jeon, So-Yeon; Lee, Namsu; Park, Chi-Young; Kim, Yeul Hong | Division of Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea; Center for Colon Cancer, National Cancer Center, Goyang, South Korea; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Internal Medicine, Gyeongsang University Hospital, Jinju, South Korea; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea; Division of Hematology-Oncology, Department of Internal Medicine, Soon Chun Hyang University, Bucheon Hospital, Bucheon-si, South Korea; Department of Hemato-oncology, Inje University, Haeundae Paik Hospital, Busan, South Korea; Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Division of Hematology and Medical Oncology, Department of Internal Medicine, Konyang University Hospital, Daejeon, South Korea; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, South Korea; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea; Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea; Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, South Korea; Division of Hematology/Oncology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Gyeonggi-do, South Korea; Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, South Korea; Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea; Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, South Korea; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea; Department of Hematology-Oncology, Inha University College of Medicine and Hospital, Incheon, South Korea; Department of Oncology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea; Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, South Korea; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, South Korea; Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, South Korea; Division of Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea | 57189064876; 57203061340; 57967744400; 57225302903; 56590181100; 7409872158; 55757077600; 57190689321; 59501049300; 7201614898; 59442246300; 54978384000; 14620681300; 56596320900; 59067164900; 57192647681; 6603306077; 56557243800; 27171619200; 56075661600; 57196250869; 27170288800; 57157836700; 56648383500; 55194346500; 35083799500; 57200867767; 57221436158 | jhmnkim@naver.com; | Anticancer Research | ANTICANCER RES | 0250-7005 | 1791-7530 | 44 | 1 | SCIE | ONCOLOGY | 2024 | 1.7 | 79.3 | 1.05 | 2025-04-16 | 2 | Colorectal cancer; efficacy; mutation status; primary tumor location; treatment patterns | Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Prognosis; Rectal Neoplasms; aflibercept; bevacizumab; capecitabine; cetuximab; fluorouracil; folinic acid; irinotecan; oxaliplatin; antineoplastic agent; bevacizumab; camptothecin; cetuximab; fluorouracil; folinic acid; adult; aged; Article; body mass; cancer combination chemotherapy; cancer prognosis; cancer survival; controlled study; demographics; ECOG Performance Status; female; Functional Assessment of Cancer Therapy Colorectal; human; inoperable cancer; longitudinal study; major clinical study; male; metastasis resection; metastatic colorectal cancer; multicenter study; observational study; palliative chemotherapy; progression free survival; quality of life; treatment response; clinical trial; colon tumor; colorectal tumor; genetics; pathology; prognosis; rectum tumor | English | Final | 2024 | 10.21873/anticanres.16818 | 바로가기 | 바로가기 | 바로가기 | |||||||
| ○ | ○ | Review | A new species of the genus Acklandia Hennig (Diptera: Anthomyiidae) from Korea with checklist and key to species of the genus | To date, only five species of the genus Acklandia Hennig have been recorded worldwide, and all species are known only in the Palaearctic region. Among the known species, Acklandia servadeii is an important and highly harmful pest in Europe, causing severe damage to iris flower buds. However, there are still no data on the biological characteristics of other species. Herein, we describe the detailed morphological characteristics and provide photographs of a new species, Acklandia tenuipenis sp. nov. We also provide a checklist and key to species of this genus in this manuscript. | Kim, Young-Kun; Suh, Sang Jae | Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; Kyungpook Natl Univ, Dept Plant Med, Daegu 41566, South Korea; Kyungpook Natl Univ, Inst Plant Med, Daegu, South Korea | 57222033782; 15754843200 | sjsuh@knu.ac.kr; | ORIENTAL INSECTS | ORIENT INSECTS | 0030-5316 | 2157-8745 | 58 | 3 | SCIE | ENTOMOLOGY | 2024 | 0.6 | 79.5 | 0 | 2025-04-16 | 0 | 0 | Anthomyiidae; Acklandia; Acklandia tenuipenis; new species; Korea | Acklandia; Acklandia tenuipenis; Anthomyiidae; Korea; new species | English | 2024 | 2024-07-02 | 10.1080/00305316.2023.2294796 | 바로가기 | 바로가기 | 바로가기 | 바로가기 |
페이지 이동: